P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio...

P2.01-34 Prognostic Value of Neutrophil to Lymphocyte Ratio for Metastatic NSCLC Patients Treated with Immunotherapy and Ramucirumab Plus Docetaxel.

Fughhi, I., Bonomi, P., Fidler, M.J., Basu, S., Borgia, J., Batus, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.1088
Date:
October, 2018
File:
PDF, 217 KB
2018
Conversion to is in progress
Conversion to is failed